• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌调强放射治疗过程中通过可变形配准方法评估解剖学和剂量学变化。

Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma.

作者信息

Lu Jie, Ma Yidong, Chen Jinhu, Wang Liming, Zhang Guifang, Zhao Mukun, Yin Yong

机构信息

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, 440 Jiyan Road, Jinan, 250117, China.

出版信息

J Radiat Res. 2014 Jan 1;55(1):97-104. doi: 10.1093/jrr/rrt076. Epub 2013 May 31.

DOI:10.1093/jrr/rrt076
PMID:23728319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3885110/
Abstract

The aim of this study was to quantify the anatomic variations and the dosimetric effects accessed by a deformable registration method throughout the entire course of radiotherapy, and to evaluate the necessity of replanning for patients with nasopharyngeal carcinoma (NPC). Plan1(CT1) was based on the original CT, and Plan2(CT2) was generated from the midtreatment CT scan acquired after 25 fractions of IMRT of Plan1. Both sets of CTs, RT structures and RT doses for the two group plans were transferred to a workstation, and then a hybrid IMRT plan, Plan1(CT2), was generated by deforming doses of Plan1 to CT2. Subsequently, the accumulated plan, Plan1 + 2(CT2), was generated to quantify the actual dosimetric effects during the course. The transverse diameter of the neck at the center of the odontoid process was (15.4 ± 1.0) cm and (14.4 ± 1.1) cm in CT1 and CT2, respectively (P < 0.05). Compared with CT1, the mean volumes of the right and left parotid glands were significantly decreased by (24.6 ± 11.9)% and (35.1 ± 20.1)%, respectively. Comparison of Plan1 (CT1) with Plan1 (CT2) indicated that the doses to targets decreased without replanning. With repeated CT and replanning after 25 fractions, the doses to targets would be improved. The doses to normal tissue were increased without replanning. For eight patients out of 12, the doses to the spinal cord and brainstem exceeded the constraints without replanning, while the corresponding values decreased with replanning. During the entire course of IMRT, the volumes of the targets and the parotid glands would be reduced significantly. Midtreatment CT scanning and replanning are recommended to ensure adaptive doses to the targets and critical normal tissues.

摘要

本研究的目的是通过可变形配准方法量化鼻咽癌(NPC)患者在整个放疗过程中的解剖学变化和剂量学效应,并评估重新计划的必要性。计划1(CT1)基于原始CT,计划2(CT2)则由计划1进行25次调强放疗(IMRT)后获得的治疗中期CT扫描生成。将两组CT、放疗结构和放疗剂量转移至工作站,然后通过将计划1的剂量变形至CT2生成混合IMRT计划,即计划1(CT2)。随后,生成累积计划,即计划1 + 2(CT2),以量化疗程中的实际剂量学效应。齿突中心处颈部的横向直径在CT1和CT2中分别为(15.4 ± 1.0)cm和(14.4 ± 1.1)cm(P < 0.05)。与CT1相比,右侧和左侧腮腺的平均体积分别显著减少了(24.6 ± 11.9)%和(35.1 ± 20.1)%。计划1(CT1)与计划1(CT2)的比较表明,无需重新计划,靶区剂量降低。在25次分割后重复CT并重新计划,靶区剂量将得到改善。未重新计划时,正常组织的剂量增加。12例患者中有8例,未重新计划时脊髓和脑干的剂量超过了限制,而重新计划后相应值降低。在整个IMRT疗程中,靶区和腮腺的体积将显著减小。建议进行治疗中期CT扫描和重新计划,以确保对靶区和关键正常组织给予适应性剂量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb8/3885110/930041f4d9a1/rrt07603.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb8/3885110/7a341bc4e2f0/rrt07601.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb8/3885110/168e5313b4db/rrt07602.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb8/3885110/930041f4d9a1/rrt07603.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb8/3885110/7a341bc4e2f0/rrt07601.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb8/3885110/168e5313b4db/rrt07602.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bb8/3885110/930041f4d9a1/rrt07603.jpg

相似文献

1
Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma.鼻咽癌调强放射治疗过程中通过可变形配准方法评估解剖学和剂量学变化。
J Radiat Res. 2014 Jan 1;55(1):97-104. doi: 10.1093/jrr/rrt076. Epub 2013 May 31.
2
Anatomical changes and dosimetric analysis of the neck region based on FBCT for nasopharyngeal carcinoma patients during radiotherapy.基于锥形束 CT 的鼻咽癌患者放疗中颈部区域解剖变化和剂量学分析。
J Xray Sci Technol. 2024;32(3):783-795. doi: 10.3233/XST-230280.
3
[Study on the assignment method of intensity modulated radiotherapy plan for nasopharyngeal carcinoma based on MR images].基于磁共振图像的鼻咽癌调强放射治疗计划分配方法研究
Zhonghua Zhong Liu Za Zhi. 2021 Aug 23;43(8):850-855. doi: 10.3760/cma.j.cn112152-20190605-00355.
4
Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.对头颈部癌进行调强放射治疗(IMRT)期间重复进行CT成像及重新规划。
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):355-62. doi: 10.1016/j.ijrobp.2005.07.957. Epub 2005 Oct 26.
5
Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?对于局部晚期鼻咽癌,调强放疗过程中是否需要重复 CT 成像和重新计划?
Jpn J Radiol. 2013 Sep;31(9):593-9. doi: 10.1007/s11604-013-0225-5. Epub 2013 Jun 9.
6
Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy.鼻咽癌调强放疗中靶区和危及器官的剂量学变化。
Br J Radiol. 2012 Aug;85(1016):e506-13. doi: 10.1259/bjr/20695672. Epub 2011 Nov 17.
7
Study of the dose-volume parameters variation in tumor target volumes and organs at risk during nasopharyngeal carcinoma radiotherapy applying deformation registration.应用形变配准研究鼻咽癌放疗期间肿瘤靶区和危及器官的剂量体积参数变化
Transl Cancer Res. 2019 Dec;8(8):2886-2892. doi: 10.21037/tcr.2019.11.06.
8
Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.鼻咽癌调强放疗第 25 次分割前重新计划的必要性临床研究。
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):617-21. doi: 10.1016/j.ijrobp.2009.08.036. Epub 2010 Feb 6.
9
Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma.局部晚期鼻咽癌两阶段自适应调强放射治疗期间的体积和剂量学变化
Biomed Mater Eng. 2014;24(1):1217-25. doi: 10.3233/BME-130923.
10
Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.确定鼻咽癌在调强放射治疗期间进行自适应放射治疗的合适时机。
Radiat Oncol. 2015 Sep 17;10:192. doi: 10.1186/s13014-015-0498-1.

引用本文的文献

1
A subgroup analysis of locally advanced nasopharyngeal carcinoma patients with small lymph nodes and large nodes using adaptive radiotherapy.使用自适应放疗对局部晚期鼻咽癌小淋巴结和大淋巴结患者进行亚组分析。
BMC Cancer. 2025 Sep 2;25(1):1414. doi: 10.1186/s12885-025-14850-1.
2
Investigating the necessity of adaptive radiotherapy in tomotherapy of head and neck cancer patients.探讨头颈部癌患者螺旋断层放疗中自适应放疗的必要性。
Radiat Oncol. 2025 Jul 21;20(1):115. doi: 10.1186/s13014-025-02689-6.
3
Does adaptive radiotherapy for head and neck cancer favorably impact dosimetric, clinical, and toxicity outcomes?: A review.

本文引用的文献

1
The need for application-based adaptation of deformable image registration.基于应用的形变图像配准的调整需求。
Med Phys. 2013 Jan;40(1):011702. doi: 10.1118/1.4769114.
2
A novel methodology for 3D deformable dosimetry.一种用于 3D 变形剂量学的新方法。
Med Phys. 2012 Apr;39(4):2203-13. doi: 10.1118/1.3694107.
3
A novel technique to enable experimental validation of deformable dose accumulation.一种用于实现可变形剂量积累的实验验证的新方法。
适形调强放疗对头颈部肿瘤的剂量学、临床和毒性结局是否有积极影响?:综述。
Medicine (Baltimore). 2024 Jun 28;103(26):e38529. doi: 10.1097/MD.0000000000038529.
4
Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.调强适形放疗对局部晚期鼻咽癌同步放化疗患者生存的影响。
Radiat Oncol J. 2024 Mar;42(1):74-82. doi: 10.3857/roj.2023.00374. Epub 2024 Mar 18.
5
Accumulated Dose Deviation of Rotational and Residual Setup Errors on Nasopharyngeal Carcinoma Using MIM Treated by Helical Tomotherapy.螺旋断层放疗治疗鼻咽癌的旋转和残余摆位误差的累积剂量偏差。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231169601. doi: 10.1177/15330338231169601.
6
Parotid Gland Stem Cell Preservation during Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Dosimetric Analysis and Feasibility.鼻咽癌调强放射治疗期间腮腺干细胞的保护:剂量学分析及可行性
J Oncol. 2022 Jul 12;2022:4922409. doi: 10.1155/2022/4922409. eCollection 2022.
7
Multi-Organ Omics-Based Prediction for Adaptive Radiation Therapy Eligibility in Nasopharyngeal Carcinoma Patients Undergoing Concurrent Chemoradiotherapy.基于多器官组学的鼻咽癌同步放化疗患者适应性放射治疗适宜性预测
Front Oncol. 2022 Jan 31;11:792024. doi: 10.3389/fonc.2021.792024. eCollection 2021.
8
Study of the dose-volume parameters variation in tumor target volumes and organs at risk during nasopharyngeal carcinoma radiotherapy applying deformation registration.应用形变配准研究鼻咽癌放疗期间肿瘤靶区和危及器官的剂量体积参数变化
Transl Cancer Res. 2019 Dec;8(8):2886-2892. doi: 10.21037/tcr.2019.11.06.
9
CT-based dose recalculations in head and neck cancer radiotherapy: comparison of daily dose recalculations to less time-consuming approaches.基于 CT 的头颈部癌症放射治疗中的剂量重新计算:每日剂量重新计算与耗时较少的方法比较。
Strahlenther Onkol. 2019 Jun;195(6):475-481. doi: 10.1007/s00066-018-1406-z. Epub 2018 Dec 6.
10
Three-Phase Adaptive Radiation Therapy for Patients With Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiation Therapy: Dosimetric Analysis.接受调强放射治疗的鼻咽癌患者的三相自适应放射治疗:剂量学分析
Technol Cancer Res Treat. 2017 Dec;16(6):910-916. doi: 10.1177/1533034617709396. Epub 2017 May 17.
Med Phys. 2012 Feb;39(2):765-76. doi: 10.1118/1.3676185.
4
Comparison of target coverage and dose to organs at risk between simultaneous integrated-boost whole-field intensity-modulated radiation therapy and junctioned intensity-modulated radiation therapy with a conventional radiotherapy field in treatment of nasopharyngeal carcinoma.同步整合加量全野调强放射治疗与传统放疗野衔接调强放射治疗在鼻咽癌治疗中对危及器官的靶区覆盖和剂量比较。
Radiol Phys Technol. 2011 Jul;4(2):180-4. doi: 10.1007/s12194-011-0119-0. Epub 2011 May 10.
5
Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.同期调强放疗联合同步化疗治疗局部晚期鼻咽癌的局部控制、生存及晚期毒性:一项 2 期研究的长期结果。
Cancer. 2011 May 1;117(9):1874-83. doi: 10.1002/cncr.25754. Epub 2010 Nov 16.
6
Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study.每周的容积和剂量变化在头颈部癌症调强放疗同期放化疗中的变化:一项前瞻性观察研究。
Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1360-8. doi: 10.1016/j.ijrobp.2009.04.005.
7
Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.鼻咽癌调强放疗第 25 次分割前重新计划的必要性临床研究。
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):617-21. doi: 10.1016/j.ijrobp.2009.08.036. Epub 2010 Feb 6.
8
Anatomic and dosimetric changes during the treatment course of intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma.局部晚期鼻咽癌调强放射治疗过程中的解剖学和剂量学变化。
Med Dosim. 2010 Summer;35(2):151-7. doi: 10.1016/j.meddos.2009.06.007. Epub 2009 Jul 23.
9
Adaptive replanning strategies accounting for shrinkage in head and neck IMRT.考虑头颈部调强放疗中组织收缩的自适应再计划策略。
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):924-32. doi: 10.1016/j.ijrobp.2009.04.047.
10
Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.适形调强同步推量放疗治疗鼻咽癌。
Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):138-45. doi: 10.1016/j.ijrobp.2009.01.084.